Clinical Trial

Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)

Study acronym: LANACARE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 3, 2019 (before its estimated December 2021 completion). Its status may not reflect the trial's current state.
Summary
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer
Trial Details
NCT Number NCT03792854
Lead Sponsor Ludwig-Maximilians - University of Munich
Conditions Anal Cancer, Quality of Life, Chemoradiation
Enrollment 100 participants
Start Date 2018-12-01
Primary Completion 2021-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2019-01-03